Literature DB >> 3860000

Infectious and bleeding complications in patients with glycogenosis Ib.

D R Ambruso, E R McCabe, D Anderson, A Beaudet, L M Ballas, I K Brandt, B Brown, R Coleman, D B Dunger, J M Falletta.   

Abstract

Clinical, hematologic, and immunologic findings were reviewed in 21 patients with glycogenosis Ib. Fifteen of the patients suffered from moderate to severe bacterial infections. Ten patients had excessive epistaxis or bleeding from surgical sites, and eight suffered oral and anal mucosal ulceration. Sixteen of 21 patients exhibited chronic neutropenia associated with abnormalities in myeloid maturation and decreases in the bone marrow storage and peripheral marginating pools. Diminished neutrophil motility was documented in 14 of 15 patients tested, and adherence was decreased in three patients studied. Neutrophil microbicidal activity, reduction of nitroblue tetrazolium, and ingestion were normal in all patients tested. Bleeding times were prolonged in five of eight patients, and results of platelet function studies were abnormal in five individuals. Excessive bleeding in patients with glycogenoses Ia and Ib are similar and may be secondary to the functional deficiency of glucose-6-phosphatase. However, neutropenia, neutrophil dysfunction, and the resulting infectious complications are specific for Ib disease and may be related to abnormal glucose-6-phosphate transport.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860000     DOI: 10.1001/archpedi.1985.02140090053027

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  19 in total

Review 1.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Normal polymorphonuclear neutrophil function in a case of glycogen storage disease type Ib.

Authors:  E Bonioli; C Bellini; A Di Stefano; A Costa; S Canini; F Patrone
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

3.  Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib.

Authors:  Hyun Sik Jun; David A Weinstein; Young Mok Lee; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2014-02-24       Impact factor: 22.113

4.  Perioperative management of hemostasis for surgery of benign hepatic adenomas in patients with glycogen storage disease type ia.

Authors:  Alix Mollet-Boudjemline; Aurélie Hubert-Buron; Catherine Boyer-Neumann; Roxana Aldea; Dominique Franco; Pascale Trioche-Eberschweiller; Anne-Elisabeth Mas; Mylène Mabille; Philippe Labrune; Vincent Gajdos
Journal:  JIMD Rep       Date:  2011-06-22

5.  Glycogen storage disease lb and Crohn colitis in a young woman.

Authors:  M Doko; V Zjacic-Rotkvic; M Zovak; M Kopljar; E Glavan; M Radacic-Aumiler
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

6.  Localisation of the gene for glycogen storage disease type 1c by homozygosity mapping to 11q.

Authors:  C D Fenske; S Jeffery; J L Weber; R S Houlston; J V Leonard; P J Lee
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

7.  Glucose production rates in type 1 glycogen storage disease.

Authors:  J E Collins; K Bartlett; J V Leonard; A Aynsley-Green
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

8.  Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.

Authors:  Saskia B Wortmann; Johan L K Van Hove; Terry G J Derks; Nathalie Chevalier; Vijaya Knight; Andreas Koller; Esmee Oussoren; Johannes A Mayr; Francjan J van Spronsen; Florian B Lagler; Sommer Gaughan; Emile Van Schaftingen; Maria Veiga-da-Cunha
Journal:  Blood       Date:  2020-08-27       Impact factor: 22.113

9.  Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type Ib.

Authors:  A Ishiguro; T Nakahata; T Shimbo; Y Amano; K Yasui; K Koike; A Komiyama
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

10.  Bone mineralisation in type 1 glycogen storage disease.

Authors:  P J Lee; J S Patel; M Fewtrell; J V Leonard; N J Bishop
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.